Hydra Registry - UK
NCT: NCT06507579 · RECRUITING
Brief Summary
The study will evaluate the efficacy and safety of transcatheter aortic valve implantation (TAVI) using the Hydra transcatheter aortic heart valve (THV) series, in patients with severe aortic stenosis up to 1-year after the procedure. This will include an evaluation of the preservation of coronary access post implant by attempting to selectively engage both the right and left coronary arteries through standardised angiographic views. The study will also examine the utility of 72 hours of post discharge remote ambulatory continuous electrocardiogram (ECG) monitoring using the novel Checkpoint Cardio System where it is clinically appropriate.
Frequently Asked Questions
What is Hydra Registry - UK?
Hydra Registry - UK is a clinical trial registered under NCT06507579. Current status: RECRUITING.
What is the status of NCT06507579?
The current status of NCT06507579 (Hydra Registry - UK) is: RECRUITING.
When did Hydra Registry - UK start?
Hydra Registry - UK started on 2024-07-11.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.